Antje Hascher

2.1k total citations
14 papers, 1.6k citations indexed

About

Antje Hascher is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Antje Hascher has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Physiology and 3 papers in Cancer Research. Recurrent topics in Antje Hascher's work include Epigenetics and DNA Methylation (5 papers), Alzheimer's disease research and treatments (3 papers) and RNA modifications and cancer (3 papers). Antje Hascher is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Alzheimer's disease research and treatments (3 papers) and RNA modifications and cancer (3 papers). Antje Hascher collaborates with scholars based in Germany, United States and France. Antje Hascher's co-authors include Eckhard Mandelkow�, Jacek Biernat, Eva‐Maria Mandelkow, Carsten Müller‐Tidow, Wolfgang E. Berdel, Etmar Bulk, Alessandro Marra, Steffen Koschmieder, Zuzana Gažová and Marcus Pickhardt and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Antje Hascher

14 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antje Hascher Germany	14	1.1k	504	491	199	179	14	1.6k
Lenka Munoz Australia	20	1.0k 0.9×	259 0.5×	297 0.6×	165 0.8×	138 0.8×	38	2.0k
Limei Yan China	25	1.2k 1.1×	270 0.5×	887 1.8×	80 0.4×	59 0.3×	58	1.9k
Zhulun Wang United States	17	1.2k 1.0×	175 0.3×	397 0.8×	154 0.8×	51 0.3×	27	2.0k
Barbara Becattini Sweden	19	1.2k 1.0×	120 0.2×	260 0.5×	128 0.6×	88 0.5×	32	1.9k
Sandra E. Wilkinson United Kingdom	20	1.6k 1.4×	287 0.6×	284 0.6×	305 1.5×	141 0.8×	34	2.7k
Andrew D. White United States	18	1.1k 1.0×	222 0.4×	224 0.5×	260 1.3×	166 0.9×	37	2.0k
Marian Mosior United States	19	1.3k 1.1×	218 0.4×	264 0.5×	175 0.9×	59 0.3×	30	2.1k
Yuanjun He United States	18	1.2k 1.1×	125 0.2×	301 0.6×	102 0.5×	126 0.7×	34	1.8k
Sophia Schedin‐Weiss Sweden	20	844 0.7×	134 0.3×	513 1.0×	170 0.9×	198 1.1×	62	1.6k
Yvonne M. Newhouse United States	19	776 0.7×	163 0.3×	313 0.6×	129 0.6×	47 0.3×	28	1.3k

Countries citing papers authored by Antje Hascher

Since Specialization

Citations

This map shows the geographic impact of Antje Hascher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Hascher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Hascher more than expected).

Fields of papers citing papers by Antje Hascher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Hascher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Hascher. The network helps show where Antje Hascher may publish in the future.

Co-authorship network of co-authors of Antje Hascher

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Hascher. A scholar is included among the top collaborators of Antje Hascher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Hascher. Antje Hascher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Bulk, Etmar, Anne‐Sophie Ay, Mehdi Hammadi, et al.. (2015). Epigenetic dysregulation of K_Ca3.1 channels induces poor prognosis in lung cancer. International Journal of Cancer. 137(6). 1306–1317. 75 indexed citations

Bäumer, Nicole, Gabriele Köhler, Georg Evers, et al.. (2014). Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions. PLoS ONE. 9(4). e94993–e94993. 13 indexed citations

Hascher, Antje, Katja Hebestreit, Christian Rohde, et al.. (2013). DNA Methyltransferase Inhibition Reverses Epigenetically Embedded Phenotypes in Lung Cancer Preferentially Affecting Polycomb Target Genes. Clinical Cancer Research. 20(4). 814–826. 41 indexed citations

Hummel-Eisenbeiss, Johanna, Antje Hascher, Petter‐Arnt Hals, et al.. (2013). The Role of Human Equilibrative Nucleoside Transporter 1 on the Cellular Transport of the DNA Methyltransferase Inhibitors 5-Azacytidine and CP-4200 in Human Leukemia Cells. Molecular Pharmacology. 84(3). 438–450. 41 indexed citations

Bulk, Etmar, Jun Yu, Antje Hascher, et al.. (2012). Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer. PLoS ONE. 7(12). e44591–e44591. 23 indexed citations

Schmidt, L. H., Tilmann Spieker, Steffen Koschmieder, et al.. (2011). The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth. Journal of Thoracic Oncology. 6(12). 1984–1992. 464 indexed citations

Tickenbrock, Lara, Hans‐Ulrich Klein, Cristina Trento, et al.. (2010). Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival. Leukemia Research. 35(5). 620–625. 18 indexed citations

Yu, Jun, Etmar Bulk, Ping Ji, et al.. (2010). The EPHB6 Receptor Tyrosine Kinase Is a Metastasis Suppressor That Is Frequently Silenced by Promoter DNA Hypermethylation in Non–Small Cell Lung Cancer. Clinical Cancer Research. 16(8). 2275–2283. 69 indexed citations

Jeganathan�, Sadasivam, Antje Hascher, Subashchandrabose Chinnathambi, et al.. (2008). Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation. Journal of Biological Chemistry. 283(46). 32066–32076. 205 indexed citations

10.

Mylonas, Efstratios, Antje Hascher, Pau Bernadó, et al.. (2008). Domain Conformation of Tau Protein Studied by Solution Small-Angle X-ray Scattering. Biochemistry. 47(39). 10345–10353. 159 indexed citations

11.

Bulk, Etmar, Antje Hascher, Rüediger Liersch, et al.. (2008). Adjuvant Therapy with Small Hairpin RNA Interference Prevents Non–Small Cell Lung Cancer Metastasis Development in Mice. Cancer Research. 68(6). 1896–1904. 31 indexed citations

12.

Bulk, Etmar, Bülent Sargin, Utz Krug, et al.. (2008). S100A2 Induces Metastasis in Non–Small Cell Lung Cancer. Clinical Cancer Research. 15(1). 22–29. 92 indexed citations

13.

Pickhardt, Marcus, Martin von Bergen�, Zuzana Gažová, et al.. (2005). Screening for Inhibitors of Tau Polymerization. Current Alzheimer Research. 2(2). 219–226. 66 indexed citations

14.

Pickhardt, Marcus, Zuzana Gažová, Martin von Bergen�, et al.. (2004). Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells. Journal of Biological Chemistry. 280(5). 3628–3635. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact